Liang Li

4PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 06, 2026
Bridging the operational gap in population pharmacokinetic-pharmacodynamic analysis: an international perspective on the 2025 Chinese group standard.

|Jun 23, 2022
FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma.

Andrea C Baines, Rachel Ershler, Bindu Kanapuru

|Jan 12, 2020
Longitudinal model-based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer.

Wenjun Chen, Liang Li, Shuangmin Ji

|Sep 25, 2019
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.

Emily Y Jen, Xin Gao, Liang Li

Pageof 1

Frequent Collaborators

1 joint publications

Kirsten B Goldberg

1 joint publications

Andrea C Baines

1 joint publications

Olanrewaju O Okusanya

1 joint publications

Zheng Jiao